文献速递腹部CTMR

丙型肝炎相关肝硬化患者接受直接抗病毒药物治疗后发生肝细胞癌的微血管侵犯影像特征

Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis.
PubMed 文献 · Eur Radiol · 2017-09-11

回顾性队列研究纳入344例接受直接抗病毒药物治疗的丙型肝炎相关肝硬化患者,随访48-74周,29例发生肝细胞癌,41个结节中29个(70.7%)出现微血管侵犯影像特征,显著高于治疗前发生的肝细胞癌结节(17/51,33.3%,p=0.0007),结论为直接抗病毒药物治疗后肝细胞癌发生迅速且多具微血管侵犯侵袭性特征,需密切影像监测。

要点

  • 直接抗病毒药物治疗后发生的肝细胞癌结节中70.7%(29/41)出现微血管侵犯影像特征。
  • 直径10-20 mm的小结节中仍有58.6%(17/29)出现微血管侵犯影像特征。
  • 治疗后肝细胞癌微血管侵犯影像特征比例显著高于治疗前肝细胞癌结节(33.3%,17/51,p=0.0007)。

核心结论

  • 丙型肝炎相关肝硬化患者接受直接抗病毒药物治疗后肝细胞癌发生迅速,多数肿瘤结节具有微血管侵犯的侵袭性影像特征,需密切影像评估。

研究设计与样本

  • 回顾性队列研究,纳入344例接受直接抗病毒药物治疗的丙型肝炎相关肝硬化连续患者,随访48-74周,采用已建立的微血管侵犯影像标准分析肝细胞癌特征并与非直接抗病毒治疗后发生的结节比较。

关键影像表现/征象

  • 直接抗病毒药物治疗后29例发生肝细胞癌,其中单结节18例、多结节11例,共检出41个结节(新发14个、复发27个)。
  • 结节最大直径10-20 mm者27个,20-50 mm者13个,大于50 mm者1个。
  • 41个结节中29个(70.7%,CI 54-84)出现微血管侵犯影像特征,直径10-20 mm的29个结节中17个(58.6%,CI 39-76)出现微血管侵犯影像特征。

诊断标准与关键数值

  • 采用已建立的微血管侵犯影像标准评估肝细胞癌结节。
  • 直接抗病毒药物治疗后肝细胞癌结节微血管侵犯影像特征比例为70.7%(29/41,CI 54-84)。
  • 直接抗病毒药物治疗前发生的肝细胞癌结节微血管侵犯影像特征比例为33.3%(17/51,CI 22-47),两组比较p=0.0007。

临床应用与阅片要点

  • 丙型肝炎相关肝硬化患者接受直接抗病毒药物治疗后需密切影像评估。
  • 直接抗病毒药物治疗后发生的肝细胞癌结节多数具有微血管侵犯影像特征,提示更具侵袭性进展。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate imaging features of microvascular invasion (MVI) in hepatocellular carcinoma (HCC) developed after direct-acting antiviral (DAA) therapy in HCV-related cirrhosis.

METHODS: Retrospective cohort study on 344 consecutive patients with HCV-related cirrhosis treated with DAA and followed for 48-74 weeks. Using established imaging criteria for MVI, HCC features were analysed and compared with those in nodules not occurring after DAA.

RESULTS: After DAA, HCC developed in 29 patients (single nodule, 18 and multinodular, 11). Median interval between therapy end and HCC diagnosis was 82 days (0-318). Forty-one HCC nodules were detected (14 de novo, 27 recurrent): maximum diameter was 10-20 mm in 27, 20-50 mm in 13, and > 50 mm in 1. Imaging features of MVI were present in 29/41 nodules (70.7%, CI: 54-84), even in 17/29 nodules with 10-20 mm diameter (58.6%, CI: 39-76). MVI was present in only 17/51 HCC nodules that occurred before DAA treatment (33.3%, CI: 22-47) (p= 0.0007). MVI did not correlate with history of previous HCC.

CONCLUSIONS: HCC occurs rapidly after DAA therapy, and aggressive features of MVI characterise most neoplastic nodules. Close imaging evaluations are needed after DAA in cirrhotic patients.

KEY POINTS: • In HCV cirrhosis, hepatocellular carcinoma develops soon after direct-acting antiviral therapy. • HCC presents imaging features of microvascular invasion, predictive of more aggressive progression. • Cirrhotic patients need aggressive and close monitoring after direct-acting antiviral therapy.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Renzulli M, Buonfiglioli F, Conti F, et al. Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis. Eur Radiol. 2017. PMID: 28894901. doi:10.1007/s00330-017-5033-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。